Bond.az White LogoBond.az Black Logo

Grupo Mateus Q1 2026: EPS Misses Estimates, Stock Steady

Grupo Mateus Q1 2026 EPS missed by 30.53%, revenue slightly below. Shares stable up 0.47%.

Robert Moore
ByRobert Moore- Senior Editor
|
0

Grupo Mateus SA (GMAT) reported Q1 2026 earnings with EPS of $0.1042, missing the $0.15 consensus by 30.53%. Revenue fell slightly short at $10.15 billion versus $10.26 billion forecast.

Despite the miss, shares rose 0.47% to close at $4.31, suggesting investors are focusing on strategic initiatives.

Gross revenue reached BRL 2.7 billion, up 13% year-over-year, though same-store sales declined 7.3%.

According to Bond.az data, GMAT3 trades at a P/E of 5.36 with a dividend yield of 5.81%, near its 52-week low.

More News
Today / 16:34
|
227

Presidio Production Q1 2026 results after merger

Presidio Production Q1 2026 results: merger impact, dividend growth, and operational focus. Read more on Bond.az.

0
Today / 16:33
|
959

Moltiply Group Q1 2026: Strong Growth Amid Challenges

Moltiply Group Q1 2026 results: revenues up 36.5%, stock down 9.87%. Despite energy challenges, the company maintains growth trajectory with AI and tech investments.

0
Today / 16:03
|
656

Onex Corp Q1 2026: Solid Results

Onex Corporation Q1 2026: Solid results driven by Convex platform and strong capital generation. Stock undervalued according to analysis.

0
Today / 16:02
|
944

RBC Bearings Q4 2026 Earnings Beat Expectations

RBC Bearings reported strong Q4 fiscal 2026 results with EPS and revenue beating expectations, driven by Aerospace & Defense growth.

0
Today / 15:33
|
912

TOMI Q1 2026: Revenue growth and 13% stock surge

TOMI Environmental Solutions Q1 2026 revenue rose 5% to $1.65M, stock surged 13%. EPS missed but investor confidence remained high.

0
Today / 15:31
|
482

ARS Pharma Misses Q1 2026 EPS Forecast, Stock Drops

ARS Pharma Q1 2026 EPS miss leads to 8.56% stock drop. Neffy prescriptions triple but high costs pressure profits.

0
Today / 15:31
|
228

American Strategic Co. Revenue Drops in Q1 2026

American Strategic Investment Co. revenue drops 40.7% in Q1 2026. Stock at $9.90. Bond.az analysis suggests undervaluation.

0
Today / 15:10
|
220

Tupy S.A. Q1 2026 loss, revenue beats expectations

Tupy S.A. Q1 2026 results: EPS misses expectations, but revenue beats. Stock declines, but Bond.az analysis shows value potential.

0
Today / 14:40
|
577

Sumitomo Pharma Q4 2025 Beats EPS Forecasts

Sumitomo Pharma Q4 2025 earnings beat EPS forecasts. The company achieved record profitability in FY 2025, driven by strong U.S. sales of ORGOVYX and GEMTESA.

0
Today / 13:51
|
928

MiNK Therapeutics Q1 2026: Strategic Progress

MiNK Therapeutics Q1 2026 earnings: strategic progress, financial results, and updates on AGENT-797 platform.

0
Today / 13:24
|
927

Kepler Weber Q1 2026: Mixed Results

Kepler Weber reported mixed Q1 2026 results with international growth offsetting domestic declines. EBITDA margin stable at 11%.

0
Today / 13:22
|
695

Acumen Pharmaceuticals Beats Q1 2026 EPS Forecast

Acumen Pharmaceuticals beats Q1 2026 EPS forecast with -$0.33, but stock falls on cautious sentiment. Details on ALTITUDE-ad trial and EBD program.

0
...
Grupo Mateus Q1 2026: EPS Misses Estimates, Stock Steady | Bond.az